https://www.newsmax.com/newsfront/COS-DRG-HEA-INDUSTRIES/2020/10/28/id/994206

Regeneron Pharmaceuticals Inc. said data from a late-stage clinical trial suggest that its antibody cocktail therapy for COVID-19 significantly reduces virus levels and the need for further medical care. The results offer another encouraging signal in the race to find…

You Might Like
Learn more about RevenueStripe...